Stay Updated with the Latest BeOne Medicines AG ONC News in Real Time
Find ONC news now at Meyka AI. Stay informed with the latest BeOne Medicines AG stocks updates, including price news, market analysis, and expert insights.
Roche Share Price Dips After UBS Downgrade to Neutral
UBS cut Roche to Neutral on November 2 but raised its target to CHF 420. We explain why the Roche share price slipped to CHF 397.20, what giredestrant means and what analysts expect next.
France Travel Reimbursement: Why ‘Remboursement’ Just Spiked on Google Trends
France travel reimbursement is suddenly one of the most-searched finance topics in the country. The term “remboursement” surged past 10K searches on Google Trends France in the last 24 hours, driven by travellers heading abroad for the Toussaint holidays who want to know one thing: how do I get my money back if I pay…
U.S. Customs Rule Tightens Canadian Drug Imports Starting October 22
U.S. Customs and Border Protection enforces new rule October 22 requiring declaration of prescription drug imports over $100 from Canada, affecting millions of uninsured Americans seeking affordable medications.
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review. This marks AstraZeneca’s second major trial halt…
ASX Stocks Performance: CSL Climbs After Clinical Trial Update Boosts Healthcare Stocks
CSL shares surged nearly 7% on the ASX on Wednesday, July 29, 2026, leading a broad healthcare rally. The biotechnology giant climbed to around A$123.68 after unveiling plans for new clinical trials tied to its Horizon 2 manufacturing process. Healthcare stocks on the ASX jumped nearly 4% at midday, outpacing every other sector. The S&P/ASX…
TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25
Australia’s TGA warns GLP-1 drugs like Ozempic and Mounjaro linked to 36 cases of NAION, a rare eye disorder causing permanent blindness. No treatment available.
TGA Warns GLP-1 Drugs Like Ozempic Linked to Rare Eye Blindness July 25
Australia’s TGA warns GLP-1 drugs like Ozempic may cause NAION, a rare eye disorder leading to blindness. 36 cases reported. No treatment available. Patients urged to seek urgent medical attention if vision changes occur.
GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24
New BMJ study finds GLP-1 weight loss drugs like Ozempic and Mounjaro linked to 37-68% higher hair loss risk. Researchers say the absolute risk remains low and hair loss is typically reversible.
Graham’s Family Dairy Recalls Milk at Tesco and Major UK Supermarkets Over Antibiotic Contamination
Graham’s Family Dairy recalls semi-skimmed milk at UK supermarkets including Tesco over possible antibiotic contamination. Bottles with best-before date 31 July 2026 affected. Full refunds available.